Skip to content

PolitiKit

Lobbying by Boehringer Ingelheim (Canada) Ltd.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Boehringer Ingelheim (Canada) Ltd.

Meetings this Parliament
4
With MPs
0
Since Nov 2021
4
Active registrations
1

Most recent reported meeting: Nov 17, 2025.

Registrations in effect

Consultant In effect since Oct 15, 2025

Consultant Ryan Adam of Wellington Dupont

Consultant lobbyists

  • Ryan Adam

Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO)

What they're lobbying on (2)
  • Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
  • Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).

Registration 960625-381001-2. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Ryan Adam · Consultant

    • Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
    Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Read more

    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Ryan Adam · Consultant

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Ryan Adam · Consultant

    • Mike Poitras · Director of operations, Public Health Agency of Canada (PHAC)
    • Elisha Hurlock · Manager, Public Health Agency of Canada (PHAC)
    • Luke Carter · Executive Director, Indigenous, Federal, Provincial and Territorial Relations Directorate, Health Canada (HC)
    • Daniel MacDonald · Director General, Health Canada (HC)
    and 1 more
    • Russell Vallee · Manager, Health Canada (HC)
    Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Read more

    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Ryan Adam · Consultant

    • Max Lee · Senior Communications Advisor to the Minister, Health Canada (HC)
    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.